Hitoshi Tsuda

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Clinical and experimental immunology

Journal of gynecologic oncology

Breast cancer (Tokyo, Japan)

Medical oncology (Northwood, London, England)

National Defense Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Defense Medical College Apr 01 2013

Japan

Professor :: Department of Basic Pathology

Publications

Rina Tanemoto, Masaaki Higashiyama, Akira Tomioka, Suguru Ito, Akinori Mizoguchi, Shin Nishii, Kenichi Inaba, Akinori Wada, Nao Sugihara, Yoshinori Hanawa, Kazuki Horiuchi, Yoshikiyo Okada, Chie Kurihara, Yoshihiro Akita, Kazuyuki Narimatsu, Shunsuke Komoto, Kengo Tomita, Takahiro Satoh, Hitoshi Tsuda, Ryota Hokari
Chronic skin damage induces small intestinal damage via IL-13-induced apoptosis. Clinical and experimental immunology 217 (3) (2024)
Rina Tanemoto, Masaaki Higashiyama, Akira Tomioka, Suguru Ito, Akinori Mizoguchi, Shin Nishii, Kenichi Inaba, Akinori Wada, Nao Sugihara, Yoshinori Hanawa, Kazuki Horiuchi, Yoshikiyo Okada, Chie Kurihara, Yoshihiro Akita, Kazuyuki Narimatsu, Shunsuke Komoto, Kengo Tomita, Takahiro Satoh, Hitoshi Tsuda, Ryota Hokari
Chronic skin damage induces small intestinal damage via IL-13-induced apoptosis. Clinical and experimental immunology 217 (3) (2024)
Rina Tanemoto, Masaaki Higashiyama, Akira Tomioka, Suguru Ito, Akinori Mizoguchi, Shin Nishii, Kenichi Inaba, Akinori Wada, Nao Sugihara, Yoshinori Hanawa, Kazuki Horiuchi, Yoshikiyo Okada, Chie Kurihara, Yoshihiro Akita, Kazuyuki Narimatsu, Shunsuke Komoto, Kengo Tomita, Takahiro Satoh, Hitoshi Tsuda, Ryota Hokari
Chronic skin damage induces small intestinal damage via IL-13-induced apoptosis. Clinical and experimental immunology 217 (3) (2024)
Rina Tanemoto, Masaaki Higashiyama, Akira Tomioka, Suguru Ito, Akinori Mizoguchi, Shin Nishii, Kenichi Inaba, Akinori Wada, Nao Sugihara, Yoshinori Hanawa, Kazuki Horiuchi, Yoshikiyo Okada, Chie Kurihara, Yoshihiro Akita, Kazuyuki Narimatu, Shunsuke Komoto, Kengo Tomita, Takahiro Satoh, Hitoshi Tsuda, Ryota Hokari
Chronic skin damage induces small intestinal damage via IL-13-induced apoptosis. Clinical and experimental immunology (2024)
Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, Shinji Ohno, Shigehira Saji, Norikazu Masuda, Akihiko Shimomura, Nobuaki Sato, Shintaro Takao, Shozo Ohsumi, Yutaka Tokuda, Hideo Inaji, Toru Watanabe
Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial. Breast cancer (Tokyo, Japan) 29 (4) (2022)
Yusuke Kobayashi, Kenta Masuda, Akira Hiraswa, Kazuhiro Takehara, Hitoshi Tsuda, Yoh Watanabe, Katsutoshi Oda, Satoru Nagase, Masaki Mandai, Aikou Okamoto, Nobuo Yaegashi, Mikio Mikami, Takayuki Enomoto, Daisuke Aoki, Hidetaka Katabuchi, null null
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO). Journal of gynecologic oncology 33 (5) (2022)
Hitoshi Tsuda, null null
Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition). Breast cancer (Tokyo, Japan) 27 (3) (2020)
Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, Hiroaki Soyama, Tomoyuki Yoshikawa, Hitoshi Tsuda, Kenichi Furuya
Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis. Journal of gynecologic oncology 29 (2) (2017)
Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, Hiroaki Soyama, Tomoyuki Yoshikawa, Hitoshi Tsuda, Kenichi Furuya
Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas. Journal of gynecologic oncology 28 (3) (2017)
Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, Hiroko Matuura, Takahiro Sakamoto, Kazuki Takasaki, Mika Kuwahara, Kento Kato, Tomoyuki Yoshikawa, Hideki Iwahashi, Hitoshi Tsuda, Kenichi Furuya
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin. Medical oncology (Northwood, London, England) 34 (12) (2017)

Hitoshi Tsuda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hitoshi Tsuda